Head-to-head · WeighScore
Ivim Health vs KERNX Health
The verdict
KERNX Health takes it — 62.2/100 to 59.6/100.
KERNX Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Washington DC telehealth platform selling compounded semaglutide and tirzepatide on flat monthly plans, with the physician consultation billed separately per visit.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Ivim Health | KERNX Health |
|---|---|---|
| WeighScore | 59.6/100 | 62.2/100 |
| Grade | C | C |
| Scorecard rank | #338 | #276 |
| Semaglutide | $149/mo (starting dose, medication and programme fee, compounded) | $129/mo (promotional rate, plus a separate fee, compounded) |
| Tirzepatide | $224/mo (starting dose, medication and programme fee, compounded) | $199/mo (promotional rate, plus a separate fee, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #338 · C
Strengths
- Both molecules are priced on one page, each quoted as medication and programme charge included rather than as a bare drug price
- A six-month commitment brings tirzepatide down to $133/mo, and the term is published rather than hidden
- The first month of the membership is free
Where it loses points
- A $75/mo membership is marketed as a separate product, and whether it is charged on top of the $149 medication rate is not stated anywhere we could find
- The $133/mo tirzepatide rate advertised on the homepage requires a six-month commitment; the month-to-month rate is $224
- Both figures are 'starting at' rates, so the cost of a titrated dose is not published
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #276 · C
Strengths
- Publishes plan pricing openly, before any intake or account creation
- Month-to-month with no long-term contract and no multi-month prepayment
- Billing starts only after a licensed provider approves treatment
- LegitScript certification verified against the issued seal, not just the badge
Where it loses points
- Its own pricing page contradicts itself: it claims no separate consultation charges, then states a $25-$60 fee applies per visit
- The consultation fee is charged whether or not a prescription is issued
- Advertised $129 and $199 rates are time-limited founding rates; standard rates are $249 and $299
- No compounding pharmacy is named anywhere on the site
- Shipping claims conflict: a 48-hour figure on the homepage against 1-2 days to ship plus 2-3 days transit in the FAQ
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.